ALXN
Alexion Pharmaceuticals Inc
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
702 hedge funds and large institutions have $38.8B invested in Alexion Pharmaceuticals Inc in 2021 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 240 increasing their positions, 293 reducing their positions, and 101 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
702
Holders Change
-45
Holders Change %
-6.02%
% of All Funds
12.26%
Holding in Top 10
77
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+10%
% of All Funds
1.34%
New
65
Increased
240
Reduced
293
Closed
101
Calls
$108M
Puts
$402M
Net Calls
-$294M
Net Calls Change
-$230M
Top Buyers
Top Sellers
1 |
BBA
Baker Bros. Advisors
New York
|
$0 |
2 |
SC
Sculptor Capital
New York
|
$107M |
3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
$2.63M |
4 |
PC
Paulson & Co
New York
|
$0 |
5 |
Barclays
London,
United Kingdom
|
$450M |